跳到正文
原文
ClinicalTrials.gov 临床试验·· 15 小时前AI 评分32

MyeloMATCH 试验比较阿糖胞苷+柔红霉素标准方案与四种实验方案治疗新诊断高危 AML

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

AI 导读

一项 II 期 MyeloMATCH 治疗试验正在新诊断、尚未开始治疗的高危急性髓系白血病(AML)患者中,比较阿糖胞苷+柔红霉素标准方案与四种实验方案:柔红霉素+阿糖胞苷脂质体单药、阿糖胞苷+柔红霉素联合 venetoclax、阿扎胞苷联合 venetoclax、柔红霉素+阿糖胞苷脂质体联合 venetoclax。

来源:ClinicalTrials.gov 临床试验 · clinicaltrials.gov